AMRYT PHARMA
Amryt Pharma is a specialty pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt’s lead product, Episalvan, received marketing approval for the treatment of partial-thickness wounds from the European Commission in January 2016. Amryt intends to further develop Episalvan as a new treatment for a hereditary skin disorder called Epidermolysis Bullosa in both Europe and the U.S. Amryt’s earlier-stage products are focussed on developing novel, next-generation somatostatin analogue (“SSA”) peptide medicines for patients with rare neuroendocrine diseases, where there are high unmet medical needs. These include acromegaly and Cushing's disease.
AMRYT PHARMA
Industry:
Biopharma Life Science Medical Pharmaceutical
Founded:
2012-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.amrytpharma.com
Total Employee:
251+
Status:
Active
Contact:
41 79 818 31 28
Email Addresses:
[email protected]
Total Funding:
186.33 M USD
Technology used in webpage:
Domain Not Resolving Google Google Cloud Fastly Hosted Fastly Load Balancer Visual Composer Ultimate Addons Google Cloud Oregon
Similar Organizations
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Kinarus Therapeutics (SIX:KNRS)
Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-05 | Chiasma | Chiasma acquired by Amryt Pharma | N/A |
| 2019-03-20 | Aegerion Pharmaceuticals | Aegerion Pharmaceuticals acquired by Amryt Pharma | N/A |
| 2016-05-13 | Sompharmaceuticals | Sompharmaceuticals acquired by Amryt Pharma | N/A |
Investors List
Ares Management
Ares Management investment in Post-IPO Debt - Amryt Pharma
Aquilo Capital Management
Aquilo Capital Management investment in Post-IPO Equity - Amryt Pharma
Stonepine Capital Management
Stonepine Capital Management investment in Post-IPO Equity - Amryt Pharma
Amati Global Investors
Amati Global Investors investment in Post-IPO Equity - Amryt Pharma
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Equity - Amryt Pharma
Highbridge Capital Management
Highbridge Capital Management investment in Post-IPO Equity - Amryt Pharma
European Investment Bank
European Investment Bank investment in Post-IPO Debt - Amryt Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-27 | Amryt Announces Appointment of Dr Tracy Cunningham as Chief Medical Officer |
Official Site Inspections
http://www.amrytpharma.com Semrush global rank: 3.48 M Semrush visits lastest month: 3.78 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amryt Pharma"
Amryt Pharma - Crunchbase Company Profile & Funding
Amryt Pharma is a specialty pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with …See details»
Amryt Pharma
We would like to show you a description here but the site won’t allow us.See details»
Amryt Pharma | Chiesi Farmaceutici S.p.A.
Apr 12, 2023 Amryt comprises a strong and growing portfolio of commercial and development assets. For more information on Amryt, including products, please visit …See details»
Amryt Pharma Company Profile | Management and Employees List …
Www.amrytpharma.com Amryt Pharma Profile and History Amryt is a revenue generating orphan drug company focused on acquiring, developing & commercialising products that help improve …See details»
Amryt Pharma - Craft
Nov 10, 2021 Amryt Pharma has 5 employees across 7 locations and $222.54 m in annual revenue in FY 2021. See insights on Amryt Pharma including office locations, competitors, …See details»
Amryt Pharma - 2025 Company Profile - Tracxn
Apr 26, 2025 Amryt Pharma got acquired by Chiesi Pharmaceuticals on Jan 08, 2023 at an acquisition amount of $1.48B. It was facilitated by Dechert, Centerview Partners, Cooley and 9 …See details»
Amryt Pharma PLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Amryt Pharma PLC of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»
Amryt Pharma plc Company Overview, Contact Details
Feb 22, 2022 Amryt Pharma plc. Biotechnology Research Ireland 201-500 Employees. Amryt Pharma was acquired by Chiesi Farmaceutici S.p.A. (“Chiesi”) April 12, 2023. Amryt is a …See details»
Amryt Pharma - Overview, News & Similar companies - ZoomInfo
Amryt Pharma contact info: Phone number: +353 15180200 Website: www.amrytpharma.com What does Amryt Pharma do? Amryt is a revenue generating orphan drug company focused …See details»
Amryt Pharma - LinkedIn
Amryt Pharma was acquired by Chiesi Farmaceutici S.p.A. (“Chiesi”) April 12, 2023. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments …See details»
Amryt Pharma 2025 Company Profile: Valuation, Investors
Amryt Pharma General Information Description. Operator of a commercial-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics. …See details»
Amryt Pharma - Org Chart, Teams, Culture & Jobs - The Org
View Amryt Pharma's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Amryt Pharma Plc Company Profile - Overview - GlobalData
Website www.amrytpharma.com Telephone 44 20 30267257. Industry Pharmaceuticals and Healthcare . Gain access to our premium ...See details»
AMRYT PHARMA LIMITED - Companies House
AMRYT PHARMA LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Amryt Pharma | LinkedIn
Apr 12, 2023 Amryt Pharma | 15,031 followers on LinkedIn. Amryt Pharma was acquired by Chiesi Farmaceutici S.p.A. (“Chiesi”) April 12, 2023. | Amryt Pharma was acquired by Chiesi …See details»
Amryt Pharma Shareholders approve acquisition of Amryt
Mar 22, 2023 The full text of each resolution was included in the notice of the shareholder meetings posted to shareholders on February 16, 2023, and is available on the Company's …See details»
Amryt Pharma Overview | SignalHire Company Profile
Amryt Pharma is a specialty pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan …See details»
Amryt Pharma - VentureRadar
"Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases.See details»
Amryt Pharma CEO and Key Executive Team | Craft.co
Amryt Pharma's CEO, Director is Joe Wiley. Other executives include Rory Nealon, COO, CFO; Stephen Joyce, Head of Marketing, Head of APAC and 17 others. See the full leadership team …See details»
Amryt Pharma - News, Mergers and Acquisitions, Locations and …
Usearch identified 1 signals for Amryt Pharma, including: 1 Mergers and Acquisitions. Usearch discovered 1 location for Amryt Pharma. Amryt Pharma is headquartered in 45 Mespil Rd. …See details»